Pettinga Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$255K Sell
657
-99
-13% -$39.5K 0.04% 136
2026
Q2
$292K Sell
756
-35
-4% -$13K 0.05% 122
2026
Q1
$232K Sell
791
-21
-3% -$6.9K 0.04% 136
2025
Q4
$285K Buy
812
+37
+5% +$12.5K 0.05% 119
2025
Q3
$251K Hold
775
– – 0.05% 120
2025
Q2
$301K Buy
775
+1
+0.1% +$402 0.07% 108
2025
Q1
$337K Hold
774
– – 0.08% 97
2024
Q4
$285K Buy
774
+1
+0.1% +$418 0.06% 109
2024
Q3
$402K Buy
773
+1
+0.1% +$534 0.1% 87
2024
Q2
$418K Hold
772
– – 0.1% 83
2024
Q1
$400K Buy
772
+1
+0.1% +$497 0.1% 86
2023
Q4
$364K Sell
771
-195
-20% -$90.2K 0.1% 91
2023
Q3
$421K Sell
966
-315
-25% -$143K 0.13% 69
2023
Q2
$569K Hold
1,281
– – 0.17% 54
2023
Q1
$589K Buy
1,281
+1
+0.1% +$476 0.18% 52
2022
Q4
$657K Hold
1,280
– – 0.21% 59
2022
Q3
$581K Buy
1,280
+312
+32% +$149K 0.2% 59
2022
Q2
$467K Buy
968
+7
+0.7% +$3.46K 0.14% 68
2022
Q1
$472K Buy
961
+6
+0.6% +$2.74K 0.12% 75
2021
Q4
$443K Buy
955
+7
+0.7% +$2.94K 0.11% 78
2021
Q3
$353K Buy
948
+8
+0.9% +$3.04K 0.09% 78
2021
Q2
$359K Buy
940
+8
+0.9% +$3.06K 0.1% 77
2021
Q1
$334K Buy
932
+8
+0.9% +$2.57K 0.1% 73
2020
Q4
$297K Buy
924
+9
+1% +$2.76K 0.11% 70
2020
Q3
$246K Buy
915
+8
+0.9% +$2.15K 0.1% 69
2020
Q2
$239K Buy
+907
New +$242K 0.12% 67
2020
Q1
– Sell
-800
Closed -$241K – 77
2019
Q4
$241K Buy
+800
New +$220K 0.13% 76
2019
Q3
– Sell
-789
Closed -$223K – 90
2019
Q2
$223K Buy
789
+6
+0.8% +$1.64K 0.12% 85
2019
Q1
$225K Buy
+783
New +$226K 0.12% 82

Other funds holding ELV

Pettinga Financial Advisors's ELV Position: Q3 2026 in Review

Pettinga Financial Advisors reduced its Elevance Health (ELV) stake by 13% in Q3 2026, selling an estimated $39.5K and leaving 657 shares worth $255K. The position accounts for 0.04% of the portfolio, ranked #136.

Pettinga Financial Advisors first reported a position in ELV in Q1 2019 and has held it in 29 quarters since. The position peaked at $657K in Q4 2022. 105 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Pettinga Financial Advisors held 657 shares of Elevance Health worth $255K as of Q3 2026.
  • Pettinga Financial Advisors sold 99 Elevance Health shares in Q3 2026, an estimated $39.5K.
  • Elevance Health made up 0.04% of Pettinga Financial Advisors's portfolio in Q3 2026, its #136 holding.
  • Pettinga Financial Advisors first reported a position in Elevance Health in Q1 2019 and has held it in 29 quarters since.
  • Pettinga Financial Advisors's Elevance Health position peaked at $657K in Q4 2022.
  • 105 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Pettinga Financial Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.